Search Results
Slidesets
Dolutegravir used in real-life provides high rates of virological response in conjunction with a rare emergence of integrase resistance.- D. Armenia
Presented at:
European HIV Clinical Forum 2017
Slidesets
Challenges in Combination HIV Prevention in the Context of a Pandemic in Latin... - Mónica Alonso
Presented at:
Latin American Stigma & Discrimination Forum 2021
Slidesets
Last Year's Key Developments Strengthening Elimination Efforts - Jordan Feld
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Slidesets
Best practice talk; Australia | Alisa Pedrana, PhD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2018
Abstracts
HIV-DNA from rectal GALT is a valid marker to explore the viral latency
C. Stingone
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Slidesets
Setting the stage - Key challenges in elimination- Jordan Feld, MD, MPH
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Slidesets
Integrase Inhibitors and Pregnancy - Claudia Cortes, MD
Presented at:
São Paulo HIV Clinical Forum 2021
Slidesets
Has treating HBV reduced liver cancer incidence? - Jinlin Hou, MD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2014
Slidesets
Session 2_0930_Transgender Preferences Related to Long-Acting ART KT.pdf
Presented at:
APACC 2023
Slidesets
Treatment strategies in special populations (women, aging patients, late presenters) - Jürgen Rockstroh, MD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2014